Quantitative Investment Management LLC Takes $528,000 Position in McKesson Corporation $MCK

Quantitative Investment Management LLC bought a new position in shares of McKesson Corporation (NYSE:MCK) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 700 shares of the company’s stock, valued at approximately $528,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in McKesson in the second quarter valued at approximately $8,156,743,000. Norges Bank bought a new position in shares of McKesson during the 4th quarter worth approximately $1,651,137,000. Bank of America Corp DE bought a new position in shares of McKesson during the 2nd quarter worth approximately $998,896,000. Legal & General Group Plc acquired a new position in shares of McKesson during the 2nd quarter worth approximately $656,566,000. Finally, The Manufacturers Life Insurance Company acquired a new position in shares of McKesson during the 2nd quarter worth approximately $651,462,000. 85.07% of the stock is owned by institutional investors.

McKesson News Roundup

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: Market resilience despite the breach headlines: McKesson’s shares remained higher, suggesting investors may be viewing the incident as manageable for now. The company’s latest reported quarter showed revenue growth, earnings above estimates and fiscal 2027 EPS guidance of $44.20–$45.00, although those results predate the cybersecurity disclosures.
• Neutral Sentiment: Long-term performance remains a supportive backdrop: A separate report highlights the substantial wealth created by holding McKesson over the past decade. However, the article is retrospective and does not provide a new reason for near-term buying. Here’s How Much a $1000 Investment in McKesson Made 10 Years Ago Would Be Worth Today
• Negative Sentiment: McKesson confirmed a cybersecurity incident involving data exfiltration. The company is investigating what information was accessed or removed. Several reports say the attackers, identified as the ShinyHunters group, claim to have stolen as many as 284 million patient records; McKesson has not confirmed that figure or the full scope of the affected data. McKesson confirms cyberattack as hackers claim theft of patient data Hackers claim millions of patient records stolen during data breach at healthcare giant McKesson
• Negative Sentiment: Potential financial and operational consequences are significant. McKesson supplies roughly one-third of hospital prescriptions, increasing the sensitivity of any disruption. Reports also cite an alleged $55 million ransom demand and threats to publish stolen information. Possible effects include incident-response costs, regulatory scrutiny, lawsuits, customer remediation and reputational damage, though the ransom amount and breach size remain unverified. McKesson Faces $55 Million Ransom Demand After Massive Data Breach McKesson investigating cybersecurity incident

Analyst Ratings Changes

Several equities research analysts have issued reports on MCK shares. Robert W. Baird set a $1,015.00 price target on McKesson in a report on Thursday, August 6th. JPMorgan Chase & Co. decreased their price objective on shares of McKesson from $1,107.00 to $1,015.00 and set an “overweight” rating on the stock in a report on Friday, May 8th. UBS Group increased their price objective on shares of McKesson from $1,050.00 to $1,080.00 and gave the company a “buy” rating in a research report on Thursday, August 6th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $875.00 target price on shares of McKesson in a research note on Friday, May 8th. Finally, Royal Bank Of Canada started coverage on shares of McKesson in a report on Wednesday, August 19th. They set a “sector perform” rating and a $845.00 target price for the company. Fourteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, McKesson currently has an average rating of “Moderate Buy” and an average target price of $973.44.

McKesson Stock Performance

MCK stock opened at $907.95 on Wednesday. McKesson Corporation has a 52 week low of $682.35 and a 52 week high of $999.00. The company has a market capitalization of $105.86 billion, a PE ratio of 24.30, a price-to-earnings-growth ratio of 1.74 and a beta of 0.30. The company’s 50-day simple moving average is $838.95 and its 200 day simple moving average is $842.64.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $9.93 earnings per share for the quarter, topping the consensus estimate of $9.56 by $0.37. The business had revenue of $105.38 billion during the quarter, compared to analysts’ expectations of $103.88 billion. McKesson had a net margin of 1.12% and a negative return on equity of 253.21%. The business’s revenue was up 7.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $8.26 EPS. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. On average, analysts forecast that McKesson Corporation will post 44.65 EPS for the current year.

McKesson Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Tuesday, September 1st will be given a dividend of $0.94 per share. This is an increase from McKesson’s previous quarterly dividend of $0.82. This represents a $3.76 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend is Tuesday, September 1st. McKesson’s dividend payout ratio (DPR) is currently 10.06%.

Insiders Place Their Bets

In other news, CAO Napoleon B. Rutledge, Jr. sold 133 shares of the company’s stock in a transaction on Friday, June 5th. The stock was sold at an average price of $764.00, for a total transaction of $101,612.00. Following the completion of the sale, the chief accounting officer directly owned 632 shares in the company, valued at approximately $482,848. This represents a 17.39% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Brian S. Tyler sold 8,463 shares of the stock in a transaction on Tuesday, July 7th. The stock was sold at an average price of $793.56, for a total value of $6,715,898.28. Following the sale, the chief executive officer directly owned 5,919 shares in the company, valued at approximately $4,697,081.64. This trade represents a 58.84% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 22,289 shares of company stock worth $17,406,854 in the last 90 days. Company insiders own 0.06% of the company’s stock.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.